Besides being an important player in bone metabolism, OPG is a key regulator in vascular disease, prostate cancer, multiple myeloma, breast cancer, bladder carcinoma, and gastric carcinoma [4]. This evidence concerns the gene TNFRSF11B and prostate cancer.